Aspiriant LLC’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$264K Sell
2025
Q2
$311K Buy
2025
Q1
$268K Buy
2024
Q4
$264K Buy
2024
Q3
$265K Buy
2024
Q2
$225K Sell
2024
Q1
$318K Buy
2023
Q4
$278K Buy
2023
Q3
$259K Buy
2023
Q2
$216K Sell
2023
Q1
$223K Buy
2022
Q4
$271K Buy
2022
Q3
$213K Buy
2022
Q2
$213K Buy
2022
Q1
$235K Buy
2018
Q2
Sell
2018
Q1
$211K Buy